CA2136164A1 - Anti-diarrhea composition - Google Patents
Anti-diarrhea compositionInfo
- Publication number
- CA2136164A1 CA2136164A1 CA 2136164 CA2136164A CA2136164A1 CA 2136164 A1 CA2136164 A1 CA 2136164A1 CA 2136164 CA2136164 CA 2136164 CA 2136164 A CA2136164 A CA 2136164A CA 2136164 A1 CA2136164 A1 CA 2136164A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- diarrhea
- amada
- curcuma
- cramps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Insects & Arthropods (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an anti-diarrhea composition comprising a therapeutically effective amount of powder of curcuma amada and bees wax.
Description
` 2136~ ~
Title: ANTI-DIARRHE'A COMPOSITION
Inventor: Habib Choudry BACKGROUND OF THE INVENTIO~
5 Field of the invention The present invention relates to an anti-diarrhea, anti-dysentery and anti-cramp composition. More particularly it relates to a composition containing a therapeutically ef f ective amount of powder of curcuma amada and bees wax.
Descri~tion of the PriQr Art Diarrhea i8 one of the great number of diseases which af f ect young and adult poplllation . Accordingly various types of drug6 have been developed and applied to treat diarrhea. The drugs 15 used to cure diarrhea, dy6entery and cramps have associated side ef f ects .
In view of the foregoing, there has and continues to be a need for the development of a product capable of curing diarrhea, 20 dysentery and cramps symptoms with no side effects.
SUMMARY OF THE INVENTION
It is an object of this invention to provide an effective anti-diarrhea, anti-dysent~ry and anti-cramps composition, 25 especially diarrhea caused by travel or in places where clean drinking water is not available.
~ ` 2136~6~
Accordingly one aspect of this invention provides an anti-diarrhea, anti-dysentery and anti-cramp, composition comprising a therapeutically effective amount of curcuma amada powder together with bees ~ax.
The present invention also provides that therapeutically ef f ective amount of extract of curcuma amada cures diarrhea, dysentery and cramps.
Further features of the invention will be described or will become apparent in the course of the following detailed description .
DETAILED DESCRIPTION OF THE PREFERRED E~$BODI~ENT
In order that the invention may be more clearly understood, the preferred embodiment thereof will now be described in detail by way of example.
As used throughout this specification, the term "composition" refers to a ~~egime of treatment as regards diarrhea and not necessarily to a single unit dosage. Such a composition may comprise one or more units containing the same or different active ingredients adminis1 rable to an individual for the purpose 25 of treating diarrhea, dysentery and cramps. Herein, anti-diarrhea 2136~ 6~
composition refer6 to a composition administrable to a patient for the purpose of treating di~rrhea, dysentery and cramps in that individual .
The term "therapeutically effective amount" with respect to the present invention, means a pharmaceutically acceptable amount to treat diarrhea. The term "pharmaceutically acceptable"
as used throughout this specification means non-toxic and applies to compositions suitable for administration to an individual.
The term "pharmaceutically acceptable excipient" refers to those excipients normal Ly employed in pharmaceutical compositions intended for oral administration. For example, excipient may be solid or liquid and include the non-toxic pharmaceutically acceptable carriers such as glucose, lactose, dextrose, sucrose, mannitol, sorbitol, gelatine, malt, silica gel, magnesium carbonate, sodium chloride, talc, dried skim milk, glycerol, propylene, glycol, water, ethanol and the like.
Preferably the pharmaceutically acceptable ~r;ri~nt is water.
~ixture of one or more excipients may also be used.
The method to obtain extract f rom curcuma amada cannot be by no means limited to any one method. However, extract obtained from curcuma-amada in conjllnction with pharmaceutical excipient will be used in different ~veight or amount in the treatment of 21361B~
diarrhea, dysentery and cramps, depending on the strength of the extract and also the age and weight of the patient i.e. 5 mg to 50 mg dose!
Examp l e In the preparati~n, root of curcuma amada (also called mango ginger and known as amb-haldi in Urdu language) is ground into powder and bees wax melted. Then 350 mg of powder of curcuma amada and 150 mg of bees wax were combined and then were adapted for oral administration on a 36 year, 140 lb. male 6uffering from diarrhea and stomach cramps. The composition was administered again after every bowel mo-~ement to a maximum of 4 times a day.
After which the symptoms oE diarrhea and cramps were relieved. The treated individual had no complaint of diarrhea nor did he complain of any unpleasant feelings related thereto.
It i8 to be noted that present invention is by no means limited to the above example.
It will be appreciated that the above description related to the preferred embodiment by way of example only. Many variations on the invention will be obvious to those knowledgeable in the field, and such obvious variations are within the scope of the invention as described and claimed, whether or not expressly 2 5 des cribed .
Title: ANTI-DIARRHE'A COMPOSITION
Inventor: Habib Choudry BACKGROUND OF THE INVENTIO~
5 Field of the invention The present invention relates to an anti-diarrhea, anti-dysentery and anti-cramp composition. More particularly it relates to a composition containing a therapeutically ef f ective amount of powder of curcuma amada and bees wax.
Descri~tion of the PriQr Art Diarrhea i8 one of the great number of diseases which af f ect young and adult poplllation . Accordingly various types of drug6 have been developed and applied to treat diarrhea. The drugs 15 used to cure diarrhea, dy6entery and cramps have associated side ef f ects .
In view of the foregoing, there has and continues to be a need for the development of a product capable of curing diarrhea, 20 dysentery and cramps symptoms with no side effects.
SUMMARY OF THE INVENTION
It is an object of this invention to provide an effective anti-diarrhea, anti-dysent~ry and anti-cramps composition, 25 especially diarrhea caused by travel or in places where clean drinking water is not available.
~ ` 2136~6~
Accordingly one aspect of this invention provides an anti-diarrhea, anti-dysentery and anti-cramp, composition comprising a therapeutically effective amount of curcuma amada powder together with bees ~ax.
The present invention also provides that therapeutically ef f ective amount of extract of curcuma amada cures diarrhea, dysentery and cramps.
Further features of the invention will be described or will become apparent in the course of the following detailed description .
DETAILED DESCRIPTION OF THE PREFERRED E~$BODI~ENT
In order that the invention may be more clearly understood, the preferred embodiment thereof will now be described in detail by way of example.
As used throughout this specification, the term "composition" refers to a ~~egime of treatment as regards diarrhea and not necessarily to a single unit dosage. Such a composition may comprise one or more units containing the same or different active ingredients adminis1 rable to an individual for the purpose 25 of treating diarrhea, dysentery and cramps. Herein, anti-diarrhea 2136~ 6~
composition refer6 to a composition administrable to a patient for the purpose of treating di~rrhea, dysentery and cramps in that individual .
The term "therapeutically effective amount" with respect to the present invention, means a pharmaceutically acceptable amount to treat diarrhea. The term "pharmaceutically acceptable"
as used throughout this specification means non-toxic and applies to compositions suitable for administration to an individual.
The term "pharmaceutically acceptable excipient" refers to those excipients normal Ly employed in pharmaceutical compositions intended for oral administration. For example, excipient may be solid or liquid and include the non-toxic pharmaceutically acceptable carriers such as glucose, lactose, dextrose, sucrose, mannitol, sorbitol, gelatine, malt, silica gel, magnesium carbonate, sodium chloride, talc, dried skim milk, glycerol, propylene, glycol, water, ethanol and the like.
Preferably the pharmaceutically acceptable ~r;ri~nt is water.
~ixture of one or more excipients may also be used.
The method to obtain extract f rom curcuma amada cannot be by no means limited to any one method. However, extract obtained from curcuma-amada in conjllnction with pharmaceutical excipient will be used in different ~veight or amount in the treatment of 21361B~
diarrhea, dysentery and cramps, depending on the strength of the extract and also the age and weight of the patient i.e. 5 mg to 50 mg dose!
Examp l e In the preparati~n, root of curcuma amada (also called mango ginger and known as amb-haldi in Urdu language) is ground into powder and bees wax melted. Then 350 mg of powder of curcuma amada and 150 mg of bees wax were combined and then were adapted for oral administration on a 36 year, 140 lb. male 6uffering from diarrhea and stomach cramps. The composition was administered again after every bowel mo-~ement to a maximum of 4 times a day.
After which the symptoms oE diarrhea and cramps were relieved. The treated individual had no complaint of diarrhea nor did he complain of any unpleasant feelings related thereto.
It i8 to be noted that present invention is by no means limited to the above example.
It will be appreciated that the above description related to the preferred embodiment by way of example only. Many variations on the invention will be obvious to those knowledgeable in the field, and such obvious variations are within the scope of the invention as described and claimed, whether or not expressly 2 5 des cribed .
Claims (4)
1. An anti-diarrhea, anti-cramps, anti-dysentery composition comprising a therapeutically effective amount of powder of curcuma amada with bees wax.
2. An anti-diarrhea, anti-cramps, anti-dysentery composition comprising a therapeutically effective amount of extract of curcuma-amada.
3. The composition as defined in claim 1 or 2 where curcuma amada powder or extract is derived from curcuma-amada root where curcuma amada is also called mango ginger and is known as amb-haldi in Urdu language.
4. The composition defined in any one of the claims 1, 2 or 3 where the composition is adapted for oral administration to a human or an animal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2136164 CA2136164A1 (en) | 1995-03-21 | 1995-03-21 | Anti-diarrhea composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2136164 CA2136164A1 (en) | 1995-03-21 | 1995-03-21 | Anti-diarrhea composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2136164A1 true CA2136164A1 (en) | 1996-09-22 |
Family
ID=4154703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2136164 Abandoned CA2136164A1 (en) | 1995-03-21 | 1995-03-21 | Anti-diarrhea composition |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2136164A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999035116A1 (en) * | 1998-01-09 | 1999-07-15 | Ida Development A/S | Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| US6986901B2 (en) | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
-
1995
- 1995-03-21 CA CA 2136164 patent/CA2136164A1/en not_active Abandoned
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999035116A1 (en) * | 1998-01-09 | 1999-07-15 | Ida Development A/S | Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| US6235287B1 (en) | 1998-01-09 | 2001-05-22 | Ida Development A/S | Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| US6986901B2 (en) | 2002-07-15 | 2006-01-17 | Warner-Lambert Company Llc | Gastrointestinal compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004537575A (en) | Nutritional supplements and their use | |
| AU645023B2 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| WO2005115427A1 (en) | Herbal medicine composition for suppression of obesity and preparation method thereof | |
| CN113797215B (en) | Composition containing pinoresinol and cycloolivil 9-glycoside and preparation method and application thereof | |
| CN106177746A (en) | A kind of to chemical liver injury compositions with auxiliary protection function and preparation method thereof | |
| Ellis et al. | Adjunct to bile-acid treatment for gall-stone dissolution: low-dose chenodeoxycholic acid combined with a terpene preparation. | |
| JPH09208484A (en) | Active oxygen-eliminator and composition containing the same | |
| WO2022028085A1 (en) | Spray for treating cervical spondylosis and preparation method therefor | |
| USRE36606E (en) | Synergistic pharmaceutical compositions | |
| CN104873446A (en) | Cinnamon oil containing toothpaste | |
| CN110898201B (en) | A topical Chinese medicinal composition for removing food stagnation in children, and its preparation method | |
| EP1583547B1 (en) | Anti-obesity ingredients from medicinal plants and their composition | |
| JP6590233B1 (en) | Skin disease therapeutic agent and method for producing the same | |
| US5603935A (en) | Composition for the treatment of snoring and methods of use thereof | |
| CA2136164A1 (en) | Anti-diarrhea composition | |
| JP3502072B2 (en) | Health food composition for protecting liver (Healthy food composition for protecting hepatic) | |
| US20080171097A1 (en) | Product liquorice root and oak bark in combination with dexapanthenol | |
| JP2000273051A (en) | Liquid preparation whose bitter taste is masked | |
| CN108114263A (en) | A kind of external preparation for treating pain | |
| CN111214553B (en) | Composition for dispelling effects of alcohol and nourishing stomach and beverage thereof and preparation method | |
| JP2958198B2 (en) | Analgesic pharmaceutical composition | |
| JP3142192B2 (en) | Blood lipid improving agent and composition containing the same | |
| CN110960634A (en) | Gastrodia elata extract and application thereof | |
| JPH10158183A (en) | Composition for preventing and treating hangover | |
| CN103948709B (en) | Palace, a kind of Uygur medicine heat seal Meikang suppository and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |